Inflammatory Disease Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.
Another Biosimilar Gets a Green Light
The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.
Green Light for Biosimilar to Humira
The US Food and Drug Administration has approved its fourth biosimilar.
Second Biosimilar Gets FDA Nod
The US Food and Drug Administration (FDA) has approved the second-ever biosimilar, and it's meant to treat multiple conditions that affect the immune system.
How Dermatologists Could Help IBD Patients
Skin lesions are a common but unpleasant side effect of the anti-TNF drugs often used to treat patients with inflammatory bowel disease (IBD). But discontinuing treatment is not recommended.
Health Canada Endorsed Important Safety Information on Sutent (sunitinib malate) Capsules
Pfizer Canada Inc. (manufacturer of Sutent), in collaboration with Health Canada, would like to inform you about an important revision to the Product Monograph, including the consumer information section, for Sutent (sunitinib malate).
Food Allergy from the Outside In
Kids with eczema often itch. Eczema has also been linked to food allergies for some time. New research adds some insight into how this connection happens.
Mommy's Mouth: Super Pacifier Cleaner
You're out with your baby and the pacifier falls on the ground. You pop it in your mouth to "clean" it and give it back to your baby. Can that simple act affect your baby's future allergies?
Strong Acne Meds Okay for Gastro Tract
When birth control pills can't clear up acne in women, a stronger medicine is the next step. But doctors and patients have been concerned about a few of these medicines and their possible links to inflammatory bowel diseases (IBD).
No Safety Surprises from Humira
Humira (adalimumab) is a medication used to treat a variety of diseases. As the medication is being prescribed to more and more patients, researchers wanted to see if there were any side effects they didn't know about before.